What is type 2 diabetes?

Medicine

Volumn 30, Issue 1, 2002, Pages 6-10

  Nolan, John J ^a,b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013114767     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1383/medc.30.1.6.28261     Document Type: Article

References (8)

1. DeFronzo R A, Bonadonna R C, Ferrannini E. Pathogenesis of NIDDM: A Balanced Overview. Diabetologia 1992; 35: 389-97.
2. Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and Methods for a Clinical Trial in the Prevention of Type 2 Diabetes. Diabetes Care 1999; 22(4): 623-34.
3. Fajans S S, Bell G I, Polonsky K S. Molecular Mechanisms and Clinical Pathophysiology of Maturity-onset Diabetes of the Young. N Engl J Med 2001; 345: 971-80.
4. Polonsky KS, Sturis J, Bell G I. Non-insulin Dependent Diabetes Mellitus - A Genetically Programmed Failure of the Beta Cell to Compensate for Insulin Resistance. N Engl J Med 1996; 334: 777-83.
5. Reaven G M. Role of Insulin Resistance in Human Disease. Diabetes 1988; 37: 1595-607.
6. Stratton I M, Adler A I, Neil H A. Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ 2000; 321: 405-12.
7. Tuomilehto J, Lindströ m J, Erikkson J G et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle Among Subjects with Impaired Glucose Tolerance. N Engl J Med 2001; 344(18): 1343-50.
8. Turner R C, Cull C A, Frighi V, Holman R R. Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281 (21): 2005-12.